BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 18196212)

  • 1. New developments in understanding and treating neuroinflammation.
    Infante-Duarte C; Waiczies S; Wuerfel J; Zipp F
    J Mol Med (Berl); 2008 Sep; 86(9):975-85. PubMed ID: 18196212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases.
    Zipp F; Aktas O
    Trends Neurosci; 2006 Sep; 29(9):518-27. PubMed ID: 16879881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimmunology - the past, present and future.
    Nutma E; Willison H; Martino G; Amor S
    Clin Exp Immunol; 2019 Sep; 197(3):278-293. PubMed ID: 30768789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting progressive neuroaxonal injury: lessons from multiple sclerosis.
    Bar-Or A; Rieckmann P; Traboulsee A; Yong VW
    CNS Drugs; 2011 Sep; 25(9):783-99. PubMed ID: 21870889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications.
    Stadelmann C
    Curr Opin Neurol; 2011 Jun; 24(3):224-9. PubMed ID: 21455066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis: an immune or neurodegenerative disorder?
    Trapp BD; Nave KA
    Annu Rev Neurosci; 2008; 31():247-69. PubMed ID: 18558855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stop inflammation and you stop neurodegeneration in MS - YES.
    Yong HY; Yong VW
    Mult Scler; 2017 Sep; 23(10):1320-1321. PubMed ID: 28463075
    [No Abstract]   [Full Text] [Related]  

  • 8. Stop inflammation and you stop neurodegeneration in MS - NO.
    Kalincik T
    Mult Scler; 2017 Sep; 23(10):1321-1323. PubMed ID: 28463073
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunology meets neuroscience--opportunities for immune intervention in neurodegenerative diseases.
    Lynch MA; Mills KH
    Brain Behav Immun; 2012 Jan; 26(1):1-10. PubMed ID: 21664452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The good and the bad of neuroinflammation in multiple sclerosis.
    Naegele M; Martin R
    Handb Clin Neurol; 2014; 122():59-87. PubMed ID: 24507513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple Sclerosis and Neuroinflammation: The Overview of Current and Prospective Therapies.
    Bjelobaba I; Savic D; Lavrnja I
    Curr Pharm Des; 2017; 23(5):693-730. PubMed ID: 27981909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodegenerative diseases: The immunological perspective.
    Molteni M; Rossetti C
    J Neuroimmunol; 2017 Dec; 313():109-115. PubMed ID: 29153601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins as potential therapeutic agents in neuroinflammatory disorders.
    Stüve O; Youssef S; Steinman L; Zamvil SS
    Curr Opin Neurol; 2003 Jun; 16(3):393-401. PubMed ID: 12858078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoplasmic reticulum stress and inflammation in the central nervous system.
    Sprenkle NT; Sims SG; Sánchez CL; Meares GP
    Mol Neurodegener; 2017 May; 12(1):42. PubMed ID: 28545479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACAID as a potential therapeutic approach to modulate inflammation in neurodegenerative diseases.
    Toscano-Tejeida D; Ibarra A; Phillips-Farfán BV; Fuentes-Farías AL; Meléndez-Herrera E
    Med Hypotheses; 2016 Mar; 88():38-45. PubMed ID: 26880635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases.
    Stolp HB; Dziegielewska KM
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):132-46. PubMed ID: 19077110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells in brain diseases.
    Ludewig P; Gallizioli M; Urra X; Behr S; Brait VH; Gelderblom M; Magnus T; Planas AM
    Biochim Biophys Acta; 2016 Mar; 1862(3):352-67. PubMed ID: 26569432
    [No Abstract]   [Full Text] [Related]  

  • 18. The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases.
    Sommer A; Winner B; Prots I
    Mol Neurodegener; 2017 Oct; 12(1):78. PubMed ID: 29078813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Immunity and Inflammation in the Pathophysiology of Neurodegenerative Diseases.
    Fakhoury M
    Neurodegener Dis; 2015; 15(2):63-9. PubMed ID: 25591815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms underlying inflammation in neurodegeneration.
    Glass CK; Saijo K; Winner B; Marchetto MC; Gage FH
    Cell; 2010 Mar; 140(6):918-34. PubMed ID: 20303880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.